搜尋結果
Hong Kong Breast Cancer Foundation Symposium on Breast Health Education 2024 Latest Breast Cancer Diagnosis and Treatment, Integrating Traditional Chinese Medicine and Mind-Body-Spirit Healing 2024-03-06
Surgery is an important consideration in the effective treatment of breast cancer. With the continuing developments of breast cancer treatment, surgery today is less disfiguring. Options for local treatment include total mastectomy or breast-conserving surgery, axillary sentinel lymph node biopsy or removal. Women who have a mastectomy may also ...
Breast cancer has become the most common cancer affecting women in Hong Kong since 1994. Female breast cancer cases diagnosed in Hong Kong have tripled from 1,152 in 1993 to 5,565 in 2021. On average, about 15 women are diagnosed with breast cancer every day.
Breast Cancer Risk Assessment. The HKSAR government commissioned the School of Public Health of the University of Hong Kong to conduct the Hong Kong Breast Cancer Study, and developed the Online Breast Cancer Risk Assessment Tool which has been validated for Hong Kong Chinese female population.
手術治療. 手術可說是治療乳癌的關鍵「元素」，隨著近年「多手段治療」 (Multimodality treatment)的發展趨向成熟，乳癌手術的創傷性逐漸降低。. 現時可供選擇的局部性治療 (Local treatment)，包括全乳切除術或乳房保留手術、腋下前哨淋巴結切片檢查或切除術等 ...
The incidence rate of breast cancer increases among women aged over 40. Research has proven that screening can reduce the breast cancer mortality by 20 -30 percent, due to early detection and treatment. Can ultrasound imaging substitute for mammography
The later the stage of breast cancer when diagnosed, the more complex is the treatment, and a lower chance of cure. It is the mission of HKBCF to bridge the service gap. Breast cancer has been the most common cancer affecting women in Hong Kong for two decades, and the third in terms of mortality.
Early Detection Saves Lives. Hong Kong Breast Cancer Foundation is dedicated to mitigating the threat of breast cancer through education, patient support and research & advocacy.
Lapatinib (Tykerb) is a targeted breast cancer therapy with proven therapeutic effects, mainly in HER2 over-expressed breast cancers. The drug, together with the oral chemotherapeutic agent Capecitabine (Xeloda), was approved by the FDA in March 2007.
How AI software is helping spot breast cancer, especially early stage cancer, to save more lives by hastening treatment – doctors explain its value, and potential （English Only）. 2024-01-09. 行政長官夫人及香港乳癌基金會名譽贊助人李林麗嬋女士 參觀香港乳癌基金會賽馬會乳健中心（九龍）. 2023-12-12.
